Literature DB >> 28471269

Anti-pentraxin antibodies in autoimmune systemic diseases: Focus on anti-pentraxin-3 autoantibodies.

Jean-François Augusto1,2,3, Caroline Poli2, Céline Beauvillain2,4,3, Jean-François Subra1,2,3, Sebastien Jaillon5,6, Gilles Renier4, Alain Chevailler2,4,3, Xavier Puéchal7, Yves Delneste2,4,3, Pascale Jeannin2,4,3.   

Abstract

Pentraxins are soluble pattern recognition molecules implicated not only in the opsonization and removal of microorganisms but also in the clearance of modified self (i.e., dying cells). Pentraxins can be classified into short pentraxins (C-reactive protein and serum amyloid-P component) and long pentraxins with pentraxin-3 (PTX3), the prototypic one of the latter. Pentraxins are involved in various physiological or pathophysiological processes such as inflammation and autoimmunity. A breakdown in immune tolerance to pentraxins has been reported in various autoimmune diseases. In the present review, we analyzed the current knowledge concerning anti-pentraxin antibodies, with a special focus on anti-PTX3 autoantibodies.

Entities:  

Keywords:  Pentraxins; anti-pentraxin autoantibodies; autoimmune diseases; biomarkers; pentraxin-3

Mesh:

Substances:

Year:  2017        PMID: 28471269     DOI: 10.1080/08830185.2017.1284210

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  2 in total

1.  Usefulness of Plasma Pentraxin 3 Levels in Acute and Chronic Inflammatory Diseases.

Authors:  Sang Hoon Han
Journal:  J Korean Med Sci       Date:  2018-05-29       Impact factor: 2.153

Review 2.  Autoantibodies in Rheumatoid Arthritis: Historical Background and Novel Findings.

Authors:  Maria V Sokolova; Georg Schett; Ulrike Steffen
Journal:  Clin Rev Allergy Immunol       Date:  2021-09-08       Impact factor: 10.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.